*
*Calcium pyrophosphate dihydrate disease** (* * CPPD * *)|312258005|64572001
is
a rheumatologic disorder|81573002
with varied symptoms
arising|68727004
due to the accumulation
of crystals|250448002|264297004|413935006
of calcium pyrophosphate dihydrate|312258005
in the connective tissues.|181769001

It
is
more commonly|242762006
known|36692007
by alternative names
that
specify|69658003
certain clinical|17162000|58147004
or
radiographic findings,|258106000|404684003|258106000
although
neither
is
synonymous
with CPPD.

_Pseudogout_ refers|60782007|439980006
to the acute symptoms|272118002
of joint inflammation|3723001
or
synovitis|416209007
:
red,|386713009|371240000
tender,|300820003
and
swollen joints|271771009
that
may
resemble
gouty arthritis|48440001
(
a similar condition|260905004
in which monosodium urate crystals|250454001
are
deposited|46595003
within the joints|39352004|81087007
).

_Chondrocalcinosis_,|239838005
[1][2]|303183002
on the other hand,|74964007|85562004|74964007|302539009
refers|439980006
to the radiographic evidence|258106000|18669006
of calcification
in hyaline
and/or
fibrocartilage.|91685003

_Pyrophosphate arthropathy_|239834007
is
a term
that
may
refer|439980006
to either
of the above.|261183002

Statistically,
the knee joint|49076000|182204005
is
the most commonly|4757001
affected.[1]|247591002|248448006

CPPD crystal deposition disease|239838005
is
a polyarticular arthritis|255205008|3723001
(i.e.,|42146005|22971001
it
leads|88488004|236874000
to an inflammation|257552002
of several joints|261028005|39352004|261028005|81087007
in the body|279495008|123037004
)
,
although
it
may
begin|255395001
as monoarticular|255210007
(i.e.,|42146005|22971001
confined
to just one joint|421379005|39352004|421379005|81087007|421379005|302536002
).

CPPD crystals|250448002|264297004|413935006
tend
to
form|246176004
within articular tissues.|39352004|85756007

Although
,
in theory,
any joint|39352004|81087007|302536002
may
be
affected|247591002|248448006
,
statistics
show
that
the knees,|304679005
wrists,|8205005
and
hips|29836001
are
the most commonly attributed areas.|4757001|246061005|42798000

In rare cases,|84638005|398241000|84638005|413769002|103356009|398241000|103356009|413769002
pseudogout|60782007
may
affect|4065008
the spinal canal|61853006
and
cause damage|134198009|37782003
to the spinal cord.|2748008|180959008

The exact cause|134198009
of CPPD
is
unknown|261665006
,
although
increased breakdown|35105006|40091007|35105006|125366008|260366006|40091007|260366006|125366008
of adenosine triphosphate|76711004
(
the molecule|290005005
used|394850002
as energy currency|248272003|15240007
in all animals|387961004
)
,
which
results|394617004
in increased pyrophosphate levels|35105006|312278002|258395000|260366006|312278002|258395000
in joints,|39352004|81087007
is
thought to|88952004
be
one|421379005
reason|410666004
why crystals|250448002|264297004|413935006
may
develop.

There
is
some recent evidence|6493001|18669006
suggesting
that
the gene ANKH|67271001
is
involved|248448006
in crystal-related inflammatory reactions|250448002|272151006|257552002|250448002|262094002|257552002|264297004|272151006|257552002|264297004|262094002|257552002|413935006|272151006|257552002|413935006|262094002|257552002
and
inorganic phosphate transport.|259296007|57188001|259296007|360300001

Excessive calcium|260378005|5540006
(
due to hypomagnesemia|190855004
has
a potential relationship|30207005|272151006
with chondrocalcinosis,|239838005
and
magnesium supplementation|72717003
may
reduce|260400001
or
alleviate symptoms.[6]|225353007

One genetic study|421379005|3950001|110465008|421379005|3950001|224699009|421379005|255395001|110465008|421379005|255395001|224699009
found|404684003
an association|263534001|272151006
between chondrocalcinosis|239838005
and
a region|410673009
of chromosome 8q.[7]|70488008

Frequently|70232002
found|404684003
among patients|116154003
with Hemochromatosis,|399187006
Marie Warder,
the well-known Hemochromatosis activist|20572008|36692007|399187006
is
now
crippled
by this disorder|64572001
to the extent|255590007
that
she
has
to
use|277889008|419385000
a voice-recognition device|312020002|303607000|312020002|49062001
in order to
carry|288345009
on her work|261041009
as a writer.|308004006

People|125676002
with this disorder usually|64572001
first
visit
the doctor|309343006
because
inflammation|257552002
is
causing|23981006
pain|22253000
in one|421379005
or
more joints.|242762006|39352004|242762006|81087007

Hyperparathyroidism,|66999008
hypothyroidism,|40930008
hemochromatosis,|399187006
hypophosphatemia,|4996001
hypomagnesemia|190855004
and
renal osteodystrophy|16726004
are
often also|70232002
associated|47429007
with chondrocalcinosis.|239838005

Other diseases|74964007|64572001
associated|47429007
with chondrocalcinosis|239838005
are
Wilson's disease|190823004
and
osteoarthritis.|396275006

In some cases,|398241000|413769002
traumatic arthritis|58188004
can
cause|23981006|134198009
chondrocalcinosis.|239838005

In general,|60132005
the white blood cell count|767002|365630000
is
raised.|260399008

In rare instances,|84638005|103356009
patients|116154003
may
also
have
signs|72670004
of carpal tunnel syndrome.|246611002

This condition|260905004
can
also
be
associated|47429007
with Milwaukee Shoulder.|27741009|415352004

Radiography|363680008
has
a large role to|255509001
play|300776002
in the diagnosis|439401001
of chondrocalcinosis,|239838005
with radiographs,|168537006
CT scans,|77477000
MRIs,|113091000
ultrasound,|359659005
and
nuclear medicine|394649004|373205008|371572003
all
having
a part.|260726005

CT scans|77477000
and
MRIs|113091000
show
calcific masses|300848003|118538004
(usually
within the ligamentum flavum|17051003|244598002
or
joint capsule|32551008
)
,
however radiography|363680008
is
more successful.|242762006|385669000

As
with most conditions,|260905004
chondrocalcinosis|239838005
can
present|52101004|246105001
with similarity
to other diseases|74964007|64572001
such as ankylosing spondylitis|9631008
and
gout.[1][2]|90560007

Because
any medication|410942007
that
could
reduce|260400001
the inflammation|257552002
of chondrocalcinosis|239838005
bears|106970005
a risk|30207005
of causing organ damage,|23981006|410653004|37782003
treatment|276239002|416118004
is
not
advised|424900004
if
the condition|260905004
is
not
causing|23981006
pain.|22253000

For acute pseudogout,|272118002|60782007
intra-articular corticosteroid injection,|27813003|79440004
systemic corticosteroids,|31099001|79440004
non-steroidal anti-inflammatory drugs (NSAIDs),|372665008
or
,
on occasion,|84638005
high-dose colchicine.|261829003|387413002

In general, NSAIDs|60132005|372665008
are
administered|418283001
in low doses to|262459003
help
prevent
chondrocalcinosis.|239838005

However,
if
an acute attack|272118002|217315002|272118002|216299002
is
already
occurring|272120004
,
higher doses|261829003
are
administered.|418283001

If
nothing
else
works,|261041009
hydroxychloroquine|373540008
or
methotrexate|387381009
may
provide
relief.|224978009

Research
into surgical removal|118292001|128303001|128304007
of calcifications
is
underway,
however
this still
remains
an experimental procedure.[2]|71388002

CPPD
affects|4065008
people|125676002
of all
cultures|252398009|61594008
and
ethnic origins,|397731000
and
,
in the United States,|223688001
around 50%
of the population|385436007|389109008
over 85 years|258707000
of age|424144002
are
affected.|247591002|248448006

It
may
cause|23981006|134198009
considerable pain,|22253000
but
it
is
never fatal.|399166001

Women|224526002
are
at a slightly higher risk|425404009|15508007
than men,|339947000
with an estimated ratio|414135002|118586006
of occurrence|272120004
of 1.4|260305007
:
1.[2]|303183002

M
:
JNT

anat(h/c,|89177007|258322007|286551008
u,
t,
l/phys|258995007|420559008

noco
(arth/defr/
back/soft/cong,|37378003
sysi/epon,
injr

proc,
drug|410942007
(M01C,
M4

